Measured Underweight: Trim MDLZ to 75-80% of benchmark weight with catalyst-aware execution, revised stop at $61.50
Underweight rating supported by five independent technical deterioration signals (price below 10 EMA/Bollinger/VWAM, RSI rollover from 62 to 49, MACD histogram flip from +0.47 to -0.11, declining highs pattern), weak Q2 EPS at $0.40, zero buybacks in Q1 2026 vs $1.52B in Q1 2025, and 3.1% stock decline since Q2 print despite upgrade. However, genuine structural floor (intact medium-term uptrend, light pullback volume at 6.38M not capitulation, 132% FCF conversion, raised organic guidance) supports measured 75-80% trim over aggressive 60% target. The $65.10 stop is structurally incoherent for a bearish thesis and must be revised to $61.50. Catalyst stack (Jackson Hole dovish surprise potential, Grenade US rollout, KC Chiefs activation, easier Q3 comp against $0.57 EPS) creates asymmetric opportunity for catalyst-aware pacing.
| Position | Action |
|---|---|
| Current position >80% of benchmark weight | Trim to 75-80% of benchmark weight over 8-12 trading sessions at 8-12% per session |
| Before Jackson Hole symposium (Aug 28-30) | Initiate 30-40% of planned trim before Fed event |
| Close below $61.31 (50 SMA) on volume ≥8M shares | Escalate to 60% of benchmark weight |
| Price breaks below $58.24 (200 SMA) | Hard exit from position |
MDLZ is a high-quality defensive compounder coiling for its next leg up, with multiple near-term growth catalysts (Grenade US launch, NFL partnership, Oreo innovation), confirmed pricing power, and a favorable macro backdrop that makes the current pullback a gift rather than a warning.
| Indicator | Value | Signal |
|---|---|---|
| close | 62.43 | neutral |
| close_200_sma | 58.24 | bullish |
| close_50_sma | 61.31 | bullish |
| close_10_ema | 63.21 | bearish |
| rsi | 49.28 | neutral |
| macd | 0.55 | neutral |
| macd_signal | 0.66 | neutral |
| macd_histogram | -0.11 | bearish |
| bollinger_upper | 64.75 | neutral |
| bollinger_middle | 62.87 | neutral |
| bollinger_lower | 61.00 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close below $58.24 (200 SMA)
Then: Exit position entirely
Growth catalysts provide multiple revenue levers
↩ rebuts: “Bear treating MDLZ as a stodgy 2% grower with no upside”
EV: +5-8% · concedes: One quarter's EPS drop ($0.40 vs $0.49-$0.57 range) does not define a structural trend, though margin compression from cocoa/input costs is real and industry-wide; Buybacks slowed to $0 in Q1 2026 - capital returned but not deployed, though management preserving optionality for M&A or debt paydown; Jackson Hole (Aug 28-30) presents hawkish surprise risk that could compress multiples; Cocoa cost spike could pressure margins again, though MDLZ demonstrated pricing power through 2024-2025 cycle
MDLZ is fully priced at $62.43 with deteriorating momentum, rising debt, unsustainable dividend coverage, and margin pressure that makes the 18.6x forward P/E expensive for low-single-digit organic growth — downside to $58-59 is more probable than upside to $65.
· concedes: The bull identified the right structural narrative and cited real catalysts; MDLZ has distribution into tens of thousands of US retail outlets; Grenade protein bars are in a double-digit growth category; MDLZ is a real business with real brands and real cash flow; 10b5-1 plans are pre-committed and $8.5M is small relative to CEO's $85M+ position; The dividend yield of 3.3% provides some cushion; Consumer staples beta of 0.40 provides some market correlation protection; MDLZ is not going to zero — it's a quality franchise at the wrong price; The technical 'coil' concept is valid; the bear disputes direction, not the pattern; Net Debt/EBITDA of 3.2x is within manageable range (though rising)
→ vs conservative: Technical reversal call is pattern-fitting not pattern-recognition—four sessions versus seven-week uptrend with light volume and no capitulation
→ vs conservative: Dividend coverage gap of 350M is fabricated; TTM FCF 2.25B provides 13% headroom and seasonal Q4 historically exceeds 2B
→ vs conservative: GLP-1 narrative overstated as category death sentence; indulgence treats have psychological consumption occasion, not nutritional
→ vs conservative: Rotation to KO has aspartame and GLP-2 litigation tail risk; PG has zero growth in flat category; KMB price action trailing MDLZ over trailing year
→ vs conservative: Stop at 65.10 is misplaced—2.27 points above current price and not anchored to any bearish technical level
→ vs conservative: Staged trim is worst of both worlds: opportunity cost of missing upside resolution plus full downside exposure
| neutral |
| atr | 1.36 | neutral |
| vwma | 63.05 | bearish |
| volume | 6,382,399 | neutral |
Support: 62.12 · 61.31 · 61 · 58.24 | Resistance: 63.21 · 64.75 · 64.99
MDLZ shows a pullback within an uptrend: price 62.43 is 7.2% above the 200 SMA (58.24) and 1.8% above the 50 SMA (61.31), but 1.2% below the 10 EMA (63.21). RSI is neutral at 49.28, MACD histogram has turned slightly negative (-0.11 from +0.47 three weeks ago), and ATR has compressed to 1.36. Resistance sits at 63.21/64.75/64.99; critical supports at 61.31 and 58.24.
Market Cap
$79.68 billion
Trailing P/E
22.87x
Forward P/E
18.57x
PEG Ratio
1.04
Price-to-Book
3.00x
EPS (TTM)
$2.73
Forward EPS
$3.36
Dividend Yield
3.30%
Beta
0.40
52-Week High
$66.65
52-Week Low
$51.20
50-Day Avg
$61.39
200-Day Avg
$58.92
Revenue (TTM)
$39.67B
Gross Profit
$12.36B
Gross Margin
31.2%
EBITDA
$6.08B
EBITDA Margin
15.3%
Operating Margin
21.98%
Profit Margin
8.86%
Return on Equity
13.34%
Return on Assets
4.12%
Free Cash Flow
$2.25B
Book Value/Share
$20.80
Total Debt
$21.62B
Net Debt
$19.50B
Debt/Equity
82.6%
Current Ratio
0.60
Goodwill & Intangibles
$43.76B
Working Capital
($10.76B)
Tangible Book Value
($18.0B)
Strengths
Concerns
Mondelez International is a large-cap consumer defensive company with a $79.68B market cap trading at a reasonable forward P/E of 18.57x and offering an attractive 3.30% dividend yield. The company demonstrates strong cash generation ($2.25B TTM FCF) and healthy operating margins (~22%), supported by iconic global brands like Oreo, Cadbury, and Milka. Key concerns include high leverage (debt/equity of 82.6%), margin compression from commodity costs, and a dramatic slowdown in share repurchases, with Q1 2026 buybacks at $0 versus $1.52B in Q1 2025. The stock appears fairly valued with modest upside catalysts and limited downside risk in a defensive context.
Macro: Fed rate cuts in 2026: 88% odds (up +2.2pp w/w on $7.6M volume) — stable discount-rate environment supports staples multiples. US recession by EOY 2026: 8% (up +1.0pp w/w on $1.7M volume) — soft-landing base case supports consumer demand. Inflation >4.5% in 2026: 12% (down -1.0pp w/w) — disinflation intact supports pricing power and rational promotional cadence. Inflation >5% in 2026: 8% — low probability of another input-cost shock rerating. Jackson Hole Fed symposium (Aug 28-30, 2026) is the single biggest near-term macro catalyst — a hawkish surprise could pressure staples multiples while a dovish surprise could re-rate the defensive-yield complex.